Please Note: Blog posts are not selected, edited or screened by Seeking Alpha editors.

Novo Nordisk: Beaten-Down Valuation And A 3% Dividend Yield

The health care sector is filled with dividend growth stocks. Just a few of the best include Johnson & Johnson (NYSE:JNJ), Abbott Labs (NYSE:ABT), and Cardinal Health (NYSE:CAH).

These stocks are all Dividend Aristocrats - stocks with 25+ consecutive years of dividend increases. You can see the list of all 51 Dividend Aristocrats here.

But not all healthcare stocks are thriving…

On February 2, Novo Nordisk (NYSE:NVO) posted disappointing quarterly results and cut its future outlook. The news sent the stock tumbling 8%, which now trades near a five-year low.

In a way, it was appropriate for the news to come on Groundhog Day. This was the third time in the past six months that the company has cut its earnings outlook.

Novo Nordisk attributes its worsening outlook to heightened political risk in the U.S., its biggest market.

The good news, is that the prolonged downturn has presented investors with an attractive buying opportunity.

Click here to continue reading this article on Sure Dividend...